Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01567722 · ClinicalTrials.gov registry record
Collecting and Studying Tissue Samples From Patients With HIV-Associated Malignancies
A clinical trial, sponsored by AIDS Malignancy Consortium.
- Terminated
- Registry status
- 114
- Enrollment target
NCT01567722: Clinical Trial study, sponsored by AIDS Malignancy Consortium.
NCT01567722 is a clinical trial that was terminated before completion, run by AIDS Malignancy Consortium. The registered enrollment target is 114 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01567722 was terminated before completion, sponsored by AIDS Malignancy Consortium.
- TERMINATED
- Registry status
- 114 participants
- Enrollment target
Study Summary
RATIONALE: Collecting and studying tissue samples from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer. PURPOSE: This research trial studies collecting tissue samples from patients with HIV-related malignancies.
Primary Outcome
Summary of the specimens available by study arm
Interventions
- GENETIC gene expression analysis
- OTHER biologic sample preservation procedure
- GENETIC DNA analysis
- GENETIC RNA analysis
- GENETIC polymorphism analysis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 114 participants |
| Start Date | 2013-01-02 |
| Est. Completion | 2022-01-14 |
Why NCT01567722 stopped before completion
NCT01567722 is an observational study that tracks outcomes without assigning an intervention. The registered 114 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 5 interventions - of which gene expression analysis is the first listed.
NCT01567722 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01567722 about?
NCT01567722 is a clinical study titled "Collecting and Studying Tissue Samples From Patients With HIV-Associated Malignancies". RATIONALE: Collecting and studying tissue samples from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer. PURPOSE: This research trial studies collecting tissue samples from patients with HIV-related malignan...
What is the current status of trial NCT01567722?
This trial is currently terminated. The enrollment target is 114 participants. The study started on 2013-01-02. Estimated completion is 2022-01-14.
What interventions are being tested in trial NCT01567722?
The interventions under investigation include: gene expression analysis (GENETIC), biologic sample preservation procedure (OTHER), DNA analysis (GENETIC), RNA analysis (GENETIC), polymorphism analysis (GENETIC).
Who is sponsoring clinical trial NCT01567722?
This trial is sponsored by AIDS Malignancy Consortium, which has 45 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04522791 · 114 participants · Phase 2
Breathing, Relaxation, Attention Training, & Health in Older Adults (BREATHE)
- NCT04875052 · 114 participants · NA
Vibration and Post-traumatic Osteoarthritis Risk Following ACL Injury
- NCT05100342 · 114 participants
Prospective Validation of a Points Score System Predicting 30-day Survival
- NCT05224089 · 114 participants · Phase 4
Bilateral TAP and RS Blocks Using Liposomal Bupivacaine/Bupivacaine vs. Regular Bupivacaine in Laparoscopic Colectomy
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI